SCHEMBL801108

SCHEMBL801108

Cc1ccc(P(=O)(c2ccc(C)cc2)c2cc(-n3c4ccccc4c4ccccc43)cc(P(=O)(c3ccc(C)cc3)c3ccc(C)cc3)c2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPSR1 Q6W5P4 2/20 0.44
▸ MAPT P10636 5/20 0.43
▸ LMNA P02545 2/20 0.43
▸ HTT P42858 1/20 0.43
▸ KDM4E B2RXH2 3/20 0.42
▸ L3MBTL1 Q9Y468 2/20 0.42
▸ ATM Q13315 1/20 0.42
▸ AKR1C4 P17516 1/20 0.38
▸ AKR1C3 P42330 1/20 0.38
▸ AKR1C2 P52895 1/20 0.38
▸ AKR1C1 Q04828 1/20 0.38
▸ HPGD P15428 1/20 0.35
▸ POLB P06746 2/20 0.35
▸ P2RX4 Q99571 1/20 0.35
▸ SMN1; SMN2 Q16637 3/20 0.34
▸ TSHR P16473 1/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ BCHE P06276 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13781018 0.89 KDM4E (0.50) NPSR1MAPTLMNAHTTKDM4E
SCHEMBL13781033 0.88 NPSR1 (0.46) NPSR1MAPTLMNAHTTKDM4E
SCHEMBL30780039 0.87 KDM4E (0.52) NPSR1MAPTLMNAKDM4EL3MBTL1
SCHEMBL801204 0.87 KDM4E (0.52) NPSR1MAPTLMNAKDM4EL3MBTL1
SCHEMBL801131 0.87 KDM4E (0.50) NPSR1MAPTLMNAHTTKDM4E
SCHEMBL801303 0.86 L3MBTL1 (0.47) NPSR1MAPTLMNAHTTKDM4E
SCHEMBL805321 0.86 NPSR1 (0.47) NPSR1MAPTLMNAHTTKDM4E
SCHEMBL16374961 0.85 MAPT (0.37) NPSR1MAPTLMNAHTTKDM4E
SCHEMBL801146 0.85 KDM4E (0.46) NPSR1MAPTLMNAHTTKDM4E
SCHEMBL29551411 0.84 KDM4E (0.52) NPSR1MAPTLMNAKDM4EL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9278986-B2 Carbazole-based phosphine oxide compound, and organic electroluminescent device including the same SK CHEMICALS CO., LTD. (KR) 2016-03-08 — — US disclosed
US-9278986-B2 Carbazole-based phosphine oxide compound, and organic electroluminescent device including the same SK CHEMICALS CO., LTD. (KR) 2016-03-08 — — US disclosed
US-20120068168-A1 CARBAZOLE-BASED PHOSPHINE OXIDE COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME INDUSTRY-ACADEMIC COOPERATION FOUNDATION, DANKOOK UNIVERSITY (KR) 2012-03-22 — — US disclosed
US-20120068168-A1 CARBAZOLE-BASED PHOSPHINE OXIDE COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME INDUSTRY-ACADEMIC COOPERATION FOUNDATION, DANKOOK UNIVERSITY (KR) 2012-03-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120068168-A1 CARBAZOLE-BASED PHOSPHINE OXIDE COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME INPP5B, EZH2, PLCB3 NPSR1 4411/4885MAPT 2464/4885LMNA 4585/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback